clinical trial · NCT07020988
A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants
UCB Biopharma SRL·phase1·completed·n = 55
Healthy ParticipantsStaccato AlprazolamMidazolamDiazepam
brief summary
The purpose of this study is to estimate the difference in the time to onset of action between Staccato alprazolam and intravenous (iv) midazolam using changes in power in the combined spindle and β1 frequency bands in the qEEG (quantitative electroencephalogram).
started
Jun 12, 2025
primary completion
Jan 6, 2026
completion
Jan 21, 2026
last updated
Feb 20, 2026
official title
An Open Label, Single Dose, Randomized, Active Comparator, Quantitative Electroencephalogram Crossover Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Intravenous Midazolam and of Staccato Alprazolam Versus Nasal Diazepam in Healthy Study Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol